Skip to content
Citation only via OpenAlex

MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS

Svetlana Yu. Milovanova, Nikolay Alekseevich Mukhin, Ludmila Yu. Milovanova, Lidia Kozlovskaya, Victor V. Fomin

Nephrology Dialysis Transplantation · 2016 · ▲ 1 citations

Abstract

Introduction and Aims: Chronic kidney disease is widespread in the population, and the results of epidemiological studies in recent years allow to consider it as an independent predictor of development and progression of cardiovascular events (CVE), risk of which, including young patients with CKD increased in 10-100 times. In the genesis of CVE in CKD many mechanisms work. Among them, in recent years, much attention is paid to morphogenetic protein - Klotho. Experimental damage of Klotho gene in mice causes vascular calcification, pathological fractures, premature aging syndrome. At the same time, it is found that the circulating form of Klotho protein can function as a humoral factor that protects cardiovascular system: Klotho overexpression experimentally provides both renal and cardiovascular protection. The aim of the study was to evaluate the impact of traditional antihypertensive therapy on serum Klotho levels in CKD 1- 4 stages patients. Methods: The main group consisted of 110 CKD patients (1-4 stages) and the control group - of 30 age and sex matched healthy volunteers. Patients were divided into groups according to the type of received antihypertensive drugs: ACE inhibitors, angiotensin II receptor antagonists (ARA), calcium channel blockers, beta-blockers and other drugs. The groups were matched for age, sex, stage of CKD and the number of people in a group (n = 22, n = 24, n = 23, n = 21, n = 20, respectively). Patients receiving combined antihypertensive therapy were excluded. All patients signed a voluntary consent to participate in research. ELISA was used for serum Klotho study (Human alpha-Kl ELISA kit with using anti-Klotho antibodies). Blood pressure (BP) including brachial and central (aortic) pressure were measured to all the patients, as well as Pulse Wave Velocity (PWV) with a Sfigmokor device (Australia), ECG, EchoCG were performed. All patients were observed in dynamic within 1 year. The study was approved by the institute ethical committee.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/ndt/gfw188.19
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Milovanova, S.Y., Mukhin, N.A., Milovanova, L.Y., Kozlovskaya, L., &amp; Fomin, V.V. (2016). MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS. <em>Nephrology Dialysis Transplantation</em>. https://doi.org/10.1093/ndt/gfw188.19
Vancouver
Milovanova SY, Mukhin NA, Milovanova LY, Kozlovskaya L, Fomin VV. MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS. Nephrology Dialysis Transplantation. 2016. doi:10.1093/ndt/gfw188.19.
BibTeX
@article{svetlana2016MPIMPA, title = {MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS}, author = {Svetlana Yu. Milovanova and Nikolay Alekseevich Mukhin and Ludmila Yu. Milovanova and Lidia Kozlovskaya and Victor V. Fomin}, journal = {Nephrology Dialysis Transplantation}, year = {2016}, doi = {10.1093/ndt/gfw188.19}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings